| Barchart Demo Center |
$2.06
+0.01 (+0.49%)
as of May 31, 2024
as of May 31, 2024
| Last | 2.06 |
|---|---|
| Change | +0.01 (+0.49%) |
| Open | 2.07 |
| Prev. Close | 2.05 |
| Today's Range |
2.05
2.11
|
| 52wk Range |
1.54
15.95
|
| Volume | 7,100 |
| Avg Volume | 47,820 |
| Sector | SIC-2834 Pharmaceutical Preparations |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| TFFP |
 +0.49% |
 -74.09% |
 -83.59% |
| DJIA |
 +1.51% |
-2.09% |
+16.90% |
| S&P 500 |
+0.80% |
+1.01% |
+25.49% |
Key Statistics
| Annual EPS | -10.16 |
|---|---|
| Dividend Yield | 0.00% |
| P/E Ratio | N/A |
| Market Capitalization, $K | 6,350 |
| Weighted Alpha | -82.23 |
| Standard Deviation | +0.07 |
| Profit Margin | -2,251.52% |
| Beta | 1.44 |
Growth Rates
| YTD | -70.66% | |||
| 1-Year | -82.73% | |||
| 3-Year | -99.24% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
TFF Pharmaceuticals and Cleveland Clinic to Advance
GlobeNewswire - Mon May 20, 06:00AM CDT
FORT WORTH, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage...(full story)
TFFP: 2.06 (+0.01)
TFF Pharmaceuticals Provides Update on Tacrolimus
GlobeNewswire - Wed May 15, 06:00AM CDT
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial 6 out of 6 Patients Who Completed the 12-Week Treatment Have Chosen to...(full story)
TFFP: 2.06 (+0.01)
TFF Pharmaceuticals Reports First Quarter Financial
GlobeNewswire - Tue May 14, 03:05PM CDT
Growing Body of Clinical Data from Ongoing Phase 2 Trial Suggests that Tacrolimus Inhalation Powder (TFF TAC) Could Represent an Important New Innovation...(full story)
TFFP: 2.06 (+0.01)
TFF Pharmaceuticals Announces Closing of Pricing of
GlobeNewswire - Wed May 01, 04:07PM CDT
FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage...(full story)
TFFP: 2.06 (+0.01)
TFF Pharmaceuticals Announces Pricing of $4.8 Million
GlobeNewswire - Mon Apr 29, 07:00PM CDT
FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage...(full story)
TFFP: 2.06 (+0.01)